Dashboard
Portfolios
Watchlist
Community
Discover
Screener
Narratives
Your Valuation
Community
/
United States
/
Healthcare
Create a narrative
iCAD Community
NasdaqCM:ICAD Community
1
Narratives
written by author
0
Comments
on narratives written by author
6
Fair Values set
on narratives written by author
Create a narrative
iCAD
Popular
Undervalued
Overvalued
Community Investing Ideas
iCAD
AN
AnalystConsensusTarget
Consensus Narrative from 2 Analysts
SaaS Transition And AI Partnerships Will Expand Healthcare Reach
Key Takeaways Transition to a SaaS business model and strategic partnerships are expected to enhance financial predictability and drive substantial revenue growth. Global expansion and increased adoption in emerging markets are anticipated to boost ARR and profitability through scalable AI healthcare solutions.
View narrative
US$3.38
FV
14.5% overvalued
intrinsic discount
12.31%
Revenue growth p.a.
Set Fair Value
0
users have liked this narrative
0
users have commented on this narrative
5
users have followed this narrative
17 days ago
author updated this narrative
Your Valuation for
ICAD
ICAD
iCAD
Your Fair Value
US$
Current Price
US$3.87
3.0% undervalued
intrinsic discount
Growth estimate over
Annual revenue growth rate
5 Years
time period
%/yr
Decrease
Increase
Past
Future
-33m
49m
2015
2018
2021
2024
2025
2027
2030
Revenue US$40.3m
Earnings US$5.4m
Advanced
Set Fair Value